RESEARCH BEHIND WOKVEL®
Representing the natural spectrum of boswellic acids used in traditional medicine for thousands of years, WokVel® is supported by peer-reviewed clinical trials with a recommended dosage of 333mg three times a day. A major key to Boswellia’s effect on joint health is its bioavailability. In order to reduce inflammation, active boswellic acids must achieve target blood and tissue concentrations needed to address key enzymes such as 5-lipoxygenase (5-LO) responsible for joint function and flexibility.
- WokVel® Extract was shown to be bioavailable in humans, with a single dose of 333mg achieving blood levels of keto-boswellic acid (KBA) shown to address 5-lipoxygenase.
- Multiple published trials have shown statistically and clinically significant effects of WokVel® for joint health. A randomized, placebo controlled clinical study, was conducted with WokVel® Extract in 30 patients. Improvements in joint health parameters, using the WOMAC scale, were clinically and statistically significant in the group receiving WokVel® as compared to the group receiving placebo.
PROPERTIES OF WOKVEL®
We value responsible and ethically sourced products. We aim to supply our customers with innovative ingredients that adhere to an intricate quality process.